Related Experiment Video
Updated: Apr 24, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Evaluation of epicardial adipose tissue in children with chronic kidney disease
Insights
Epicardial adipose tissue was lower in children with chronic kidney disease, but did not predict cardiovascular disease risk. Further research is needed to validate epicardial adipose tissue thickness as a cardiovascular disease predictor in pediatric chronic kidney disease.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Research
- Echocardiography
Background:
- Epicardial adipose tissue (EAT) is a predictor of cardiovascular disease (CVD) in adults with diabetes, obesity, and chronic kidney disease (CKD).
- The role of EAT in predicting CVD risk in children with CKD is not well-established.
Purpose of the Study:
- To evaluate epicardial adipose tissue (EAT), carotid intima-media thickness (CIMT), and left ventricular mass index (LVMI) in children with CKD.
- To compare these parameters with those of healthy children.
Main Methods:
- A case-control study involving 23 children with CKD and 21 age- and sex-matched healthy controls.
- Transthoracic echocardiography was used to measure EAT, CIMT, and LVMI.
- Demographic and biochemical parameters were also compared.
Main Results:
- No significant differences in age, weight, height, BMI, blood pressure, glucose, calcium, phosphorus, or lipid levels were found between groups.
- Children with CKD had lower EAT thickness (6.45 ± 1.61 mm) compared to controls (7.70 ± 1.69 mm, p < 0.05).
- No significant difference in CIMT was observed between patients and controls (0.40 vs. 0.42 mm, p = 0.29).
Conclusions:
- Lower epicardial adipose tissue thickness in children with CKD warrants further investigation.
- Current findings suggest that EAT thickness may not be a reliable predictor of CVD in pediatric CKD.
- Larger, long-term studies are needed to determine the utility of EAT thickness for CVD risk estimation in pediatric CKD.
Aims:
Previous studies in adults have demonstrated that epicardial adipose tissue could be used to predict the risk of the development of cardiovascular disease in patients with diabetes mellitus, obesity, and chronic kidney disease. Herein, we aimed to evaluate epicardial adipose tissue, carotid intima-media thickness and left ventricular mass index in children with chronic kidney disease and compare the results with healthy subjects.
Materials And Methods:
23 children who were diagnosed with chronic kidney disease or received kidney replacement therapy constituted the patient group; 21 age- and sex-matched healthy subjects served as the control group. Epicardial adipose tissue, carotid intima-media thickness, and left ventricular mass index obtained by using transthoracic echocardiography, demographic and biochemical parameters were compared.
Results:
No significant difference was detected between patients and healthy controls in terms of age, weight, height, body mass index, systolic and diastolic blood pressures. Serum glucose, calcium, phosphorus, and lipid levels were also similar. Although echocardiographic examination revealed lower epicardial adipose tissue thickness and higher mass index in patients with chronic kidney disease compared to healthy subjects (6.45 ± 1.61 vs. 7.70 ± 1.69 mm, p < 0.05), no difference was observed in carotid intima-media thickness measurement (0.40 (0.37 - 0.44) vs. 0.42 (0.35 - 0.50) mm, p = 0.29).
Conclusion:
Larger and long-term studies in children are needed to use epicardial adipose tissue thickness as an effective method to estimate the development of cardiovascular disease in patients with chronic kidney disease.
Related Concept Videos
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
